[
  {
    "timestamp": "2025-12-31T10:14:17.426193",
    "content": "\ud83c\udf0d MARKET NEWS RECAP\n\nEuropean markets provided a strong counter-narrative to the US pullback, with the $DAX Index advancing 0.57% and the $Euro Stoxx 50 gaining 0.77% in a robust year-end close. US markets saw a continuation of marginal profit-taking in the final session, with the $S&P 500 easing 0.14% and the $Nasdaq Composite slipping 0.24%. Asian indices opened mixed, with the Shanghai Composite seeing minimal movement while the Hang Seng Index retreated over 1% on the last day of trading.\n\n\ud83d\udcbc PORTFOLIO FOCUS\n\nThe megacap technology sector saw continued year-end profit-taking, impacting major holdings like $NVDA, $MSFT, and $AMZN, as investors locked in gains from the AI-driven rally that fueled the $Nasdaq slip. Healthcare names $LLY and $NOVO-B.CO are consolidating after their strong run, with market attention shifting to 2026 pipeline developments and regulatory clarity. European exchange operator $DB1.DE and luxury auto firm $RACE may benefit from the regional strength seen in th"
  },
  {
    "timestamp": "2025-12-31T15:12:13.884067",
    "content": "\ud83c\udf0d MARKET NEWS RECAP\n\nGlobal markets traded with a modest year-end pullback amid extremely thin holiday volumes, with US $S&P 500 and $Nasdaq 100 futures signaling a soft open, down 0.2% and 0.3% respectively. European bourses were similarly muted, as the Stoxx Europe 600 fell 0.1% and France's CAC 40 declined 0.4% in early trading. In Asia, the $Shanghai Composite managed a marginal gain of 0.1%, contrasting with a 0.9% drop in the Hang Seng index, as investors booked profits on the final trading day of the year.\n\n\ud83d\udcbc PORTFOLIO FOCUS\n\nThe AI and chip sector, which includes $NVDA, $AVGO, $TSM, $MSFT, and $SNPS, saw a major catalyst with news of $NVDA's potential $20 billion acquisition of Groq's AI inferencing technology, positioning it for the next growth phase in AI adoption. In the GLP-1 space, $NOVO-B.CO submitted a New Drug Application (NDA) to the FDA for its once-weekly CagriSema combination for weight management, intensifying competition with $LLY. Separately, a new FDA-approved m"
  },
  {
    "timestamp": "2025-12-31T22:17:45.867978",
    "content": "\ud83c\udf0d MARKET NEWS RECAP\n\nGlobal markets closed out the final trading day of the year on a soft note amid extremely thin holiday volumes. US indices declined, with the $S&P 500 falling 0.33% and the $Nasdaq 100 down 0.34%, primarily driven by weakness in chip and data storage stocks. European stocks were also slightly lower, with the Euro Stoxx 50 easing 0.08%, while China's Shanghai Composite showed resilience, climbing 0.1% following stronger-than-expected December Manufacturing and Non-Manufacturing PMI data. The unexpected drop in US weekly jobless claims to a one-month low was a hawkish factor contributing to higher bond yields and pressure on equities.\n\n\ud83d\udcbc PORTFOLIO FOCUS\n\nThe AI and Semiconductor cohort, including $NVDA, $TSM, $AVGO, $MSFT, $SNPS, $AMZN, and $GOOG, faced selling pressure, as chip stocks led the broader $Nasdaq decline. The Healthcare sector, featuring $LLY and $NOVO-B.CO, continued to be driven by the prevailing narrative of $LLY's dominance in the GLP-1 weight-loss d"
  },
  {
    "timestamp": "2026-01-01T10:15:19.384074",
    "content": "\ud83c\udf0d MARKET NEWS RECAP\n\nGlobal financial markets were universally closed today for the New Year's Day holiday, resulting in no trading activity for major indices including the $S&P 500, $Nasdaq, and the $Euro Stoxx. The focus has entirely shifted to policy announcements and economic forecasts for the year ahead, with all eyes now on the first trading session of 2026 tomorrow. Asian markets, including the Shanghai Composite, also observed the holiday, leaving volume at negligible levels worldwide. The lack of trading volume has led analysts to issue numerous sector outlooks, setting the stage for tomorrow\u2019s open.\n\n\ud83d\udcbc PORTFOLIO FOCUS\n\nWith markets closed, attention is on the 2026 outlook for key sectors. The Healthcare cohort, including $AZN.L, $ABT, $ABBV, $LLY, and $NOVO-B.CO, is poised for continued growth based on new product pipelines and a strong M&A environment, with particular momentum expected in obesity and immunology treatments. AI and Semiconductor names like $NVDA, $TSM, $MSFT, "
  },
  {
    "timestamp": "2026-01-01T15:12:11.179788",
    "content": "\ud83c\udf0d MARKET NEWS RECAP\n\nGlobal financial markets, including the $S&P 500, $Nasdaq, and $Euro Stoxx, were universally closed today for the New Year's Day holiday, resulting in extremely limited trading activity. A key European policy event saw Bulgaria officially adopt the euro, becoming the 21st country to join the single currency. In trade news, China announced it will impose additional 55% tariffs on beef imports from key global suppliers, including the US and Australia, effective today.\n\n\ud83d\udcbc PORTFOLIO FOCUS\n\nWith no major company-specific news during the holiday, the focus remains on macro drivers for the portfolio's core holdings. The AI/Cloud infrastructure sector, including $NVDA, $AVGO, $MSFT, and $GOOG, enters the new year with strong momentum following $GOOG's best year since 2009 due to strengthening AI sentiment. Healthcare and Pharma holdings ($LLY, $NOVO-B.CO, $ABBV) are centered on upcoming Q4 earnings and continued legislative uncertainty regarding drug pricing. China's new t"
  }
]